News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - IPO (World)
Zealand Pharma  (ZEAL.CO) Prices Its Initial Public Offering Of American Depositary Shares On The Nasdaq Global Select Market In The United States 8/9/2017
Zealand Pharma  (ZEAL.CO) Commences Initial Public Offering Of American Depositary Shares In The United States 8/2/2017
BGI Genomics Completes $250 Million IPO On Shenzhen ChiNext 7/14/2017
Week In Review: Shenzhen's BGI Plans $250 Million China IPO To Support Genomics Operations 6/26/2017
Life Is Swede For Medtech IPOs 6/23/2017
BGI's $250 Million Shenzhen IPO Scheduled For July 6/20/2017
Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO 6/16/2017
As Johnson & Johnson (JNJ) Closes $30 Billion Deal, Actelion (ALIOF.PK) Spinoff Is Valued at $1.54 Billion In IPO Debut 6/16/2017
Wuxi Biologics Rises 37% in First Hong Kong Trading Session 6/15/2017
Argenx Raises Approximately $100 Million Gross Proceeds With NASDAQ IPO 5/18/2017
ASLAN To Start Taipei Exchange IPO With Three-Day Auction 5/10/2017
UroGen Announces Pricing Of Initial Public Offering 5/4/2017
Zymeworks Announces Pricing Of Initial Public Offering 4/28/2017
ASLAN Announces Intention To Launch An Initial Public Offering On Taipei Exchange 4/26/2017
Shaanxi Kanghui Pharma Completes $52 Million Shanghai IPO 4/24/2017
Galapagos (GLPG.BR) Locks In $338 Million In A U.S. Public Offering 4/18/2017
ASLAN Plans $40 Million Taiwan IPO In May 4/13/2017
Kangtai Biological Products Co. Ltd.'s Stock Price Rises 12-Fold Following Shenzhen IPO 3/17/2017
BGI Re-Files To Raise $250 Million In Shenzhen IPO 3/16/2017
UK Investment Life Sci Firm Arix Bioscience Hits £100 Million IPO Goal 2/17/2017
ObsEva (OBSV) Release: Pharma Announces Pricing Of Initial Public Offering 1/26/2017
Week In Review: China's New Century Healthcare Plans Hong Kong IPO 1/3/2017
TiGenix Announces Launch Of Proposed Initial Public Offering In The United States 12/6/2016
Verona Pharma (VRP.L) Plans To Conduct Registered Initial Public Offering In The U.S. 11/23/2016
Asymchem Laboratories, Inc., A Tianjin CMO, Raises $125 Million In Shenzhen IPO 11/21/2016
BeyondSpring Pharmaceuticals, A US-China Pharma, Files For $100 Million IPO 11/17/2016
Week In Review: Investors Embrace Future Of Biologics Drugs In Samsung Biologics ' $2 Billion IPO 11/14/2016
Week In Review: Chi-Next Exchange Rejects BGI's $260 Million IPO Application 11/7/2016
BGI's Shenzhen IPO Rejected By China Regulators 11/4/2016
ConvaTec Conjures Up 1.5 Billion Pounds in London Listing 10/26/2016
Bloomberg: Samsung Biologics And Wuxi Biologics Plan IPOs For their Biologic CMOs 10/17/2016
Week In Review: China Resources Pharmaceutical To Price $2 Billion Hong Kong IPO This Week 10/17/2016
China Resources Pharma To Start Taking Orders For $2 Billion Hong Kong IPO 10/12/2016
China Resources Pharma OK'd To Raise $2 Billion In Hong Kong IPO 9/12/2016
Week In Review: China Resources Pharma To Raise $2 Billion In Hong Kong IPO 9/12/2016
Samsung Biologics Seeks To Raise Up To $2.5 Billion From IPO 8/10/2016
Week In Review: Crown Bioscience, A US-China CRO, Applies For Taiwan Listing 8/1/2016
Advanced Enzyme IPO Kicks Off, Sees Subscription Of 89% On Day 1 7/20/2016
Spring Rain Mobile Healthcare App Raises $183 Million, Plans China IPO 6/24/2016
Merus Announces Pricing Of Initial Public Offering 5/19/2016
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016
GenScript Stages $68 Million IPO In Hong Kong 12/31/2015
Hutchison China MediTech (Chi-Med) Files For US NASDAQ IPO 10/19/2015
Strongbridge Biopharma Announces Pricing Of Its Initial U.S. Public Offering 10/16/2015
NovoCure Prices $165 Million IPO 10/2/2015
Bioceres Files for an $81 Million U.S. IPO 9/28/2015
Swedish Cancer Biotech Oasmia Narrows Range For IPO 9/16/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
Adherium $35 Million ASX IPO To Expand Sales Of Digital Health Technology To Improve Medication Adherence 8/5/2015
GC Aesthetics Files For A $75 Million IPO 6/25/2015
GC Aesthetics Files Registration Statement for Proposed Initial Public Offering 6/25/2015
Benitec (BLT.AX) Files $70 Million IPO As Gene Therapy Booms 6/24/2015
Celyad Scores $100.1 Million Gross Proceeds With NASDAQ IPO 6/19/2015
3SBio Inc. (SSRX) Sets Target Of $712 Million For Hong Kong IPO 5/28/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/15/2015
GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Raising Approximately $179.2 Million On The NASDAQ Global Market 5/6/2015
Zhejiang ChiMin Pharma Stages $47 Million IPO In Shanghai 3/23/2015
Cancer Biotech Cellectis (ALCLS) Sets Terms For $129 Million IPO 3/20/2015
Growth Hormone Biotech Ascendis Pharma A/S Files For A $86 Million IPO 12/19/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
NeuroDerm Ltd. (NDRM) IPO Disappoints 11/14/2014
Xenon Pharmaceuticals Inc. Postpones IPO 10/20/2014
Bone Biotech PolyPid Ltd. Files For A $24 Million IPO 10/16/2014
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO 9/29/2014
ProQR Therapeutics B.V. (PRQR) Prices IPO At $13 A Share 9/18/2014
Affimed Therapeutics AG (AFMD) Prices IPO At $7, Below The Range 9/12/2014
Diabetes/Alzheimer's Biotech Vitae Pharmaceuticals, Inc. Sets Terms For $60 Million IPO 9/9/2014
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
VBL Therapeutics Announces Pricing Of Initial Public Offering 7/31/2014
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares 7/31/2014
Absorbable Drugs Biotech Innocoll, Inc. Sets Terms For $75 Million IPO 7/16/2014
Italian Drugmaker Rottapharm Sets Price Range For IPO 7/8/2014
GW Pharmaceuticals Eyes $148 Million In NASDAQ Offering 6/19/2014
Orthocell IPO Opens 6/5/2014
Novo Nordisk A/S (NVO)'s IT Unit Appoints Advisers For Possible IPO 3/18/2014
Week In Review: Jiangsu Aosaikang Pharma Delays China IPO 1/20/2014
Innate Immunotherapeutics Completes $10 Million IPO 12/18/2013
uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering 11/11/2013
Beijing Genomics Institute (BGI) Shenzhen Plans IPO 9/3/2013
Belgian Heart Drug Firm Cardio3 BioSciences Launches IPO 6/21/2013
Belgian Heart Drug Firm Cardio3 BioSciences Plans to IPO in Paris, Brussels 6/5/2013
TRT Chinese Medicines Expects to IPO on ChiNext 4/11/2013
TetraPhase Pharmaceuticals, Enanta Pharmaceuticals, Inc. Prepare for IPOs 3/19/2013
China National Biotech Group's $1.5 Billion IPO is Rumored Again 1/15/2013
Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen 5/29/2012
Once Again, Fosun Pharma Plans Hong Kong IPO 2/9/2012
Foci Pharma to IPO in Shenzhen 12/6/2011
China National Biotech Group to IPO on the Hong Kong Exchange 11/7/2011
Novartis AG Broods Over a China IPO, CEO Says Drugmaker is Ready for More Deals 7/12/2011
Shandong Jincheng Pharma Completes $72 Million IPO 6/22/2011
Pfizer Inc. (PFE), Temasek to Invest in Shanghai Pharmaceutical Co., Ltd.'s IPO: Shanghai Pharma Share Sale to Raise $2.2 Billion 5/3/2011
Israeli Life Sciences Boom; Exchange Draws Flood of IPOs; Some see Symptoms of a Bubble 4/1/2011
Rosetta Genomics Ltd. (ROSG) Announces IPO of Majority-Owned Subsidiary Rosetta Green in Israel 2/22/2011
Swiss-Italian Biotech, Philogen Eyes up to 65.3 Million Euros in IPO 2/10/2011
Al-Dorra Holdings to IPO New Pharmaceutical Subsidiary, Hail First Pharma Inc. 1/21/2011
CLARIS Lifesciences Gets Nod for Rs 300-Crore IPO 11/23/2010
Japan's Otsuka Holding Company to Raise $2.8 Billion in Record Pharma IPO 11/12/2010
Zealand Pharma Mulls IPO, Seen Worth up to $560 Million 10/21/2010
Russia's Pharmsynthez Plans £10.5 Million ($16.1 Million) IPO 9/1/2010
Sichuan Kelun Pharma to Stage $735 Million IPO in Shenzhen 5/21/2010
Belgium's Taminco Cancels IPO, Cites Poor Market 2/4/2010
China Nuokang Bio-Pharmaceutical Inc. (NKBP) IPO Prices Below Range, Raises $45 Million 12/10/2009
Movetis Seeking up to 112.4 Million Euros in IPO 11/20/2009
Sinopharm IPO to Raise up to $1.13 Billion 9/4/2009
D-Pharm Ltd. Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 8/17/2009
Cheezheng Tibetan Medicine to IPO on Shenzhen Exchange 8/13/2009
Chemcel Biotech IPO to Open on September 9 9/8/2008
Will Sinopharm and CITIC IPO? 8/27/2008